Edgewise Therapeutics taps new CFO
BOULDER — Edgewise Therapeutics Inc. has hired R. Michael Carruthers, a longtime finance head for Boulder-area pharmaceutical firms, as its […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
CEO Roundtable: Boulder Valley life sciences industry shines amid COVID crisis
BOULDER — The COVID-19 pandemic is providing an opportunity for the Boulder Valley’s life sciences industry — from pharmaceutical firms,…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Edgewise Therapeutics reports continued successful drug trials, $17.4M loss in third quarter
BOULDER — Edgewise Therapeutics Inc. (Nasdaq: EWTX) reported continued successful drug trials in the third quarter of 2022 as the…
Edgewise Therapeutics receives FDA approval for muscular dystrophy drug trials, launches stock offering
BOULDER — Edgewise Therapeutics Inc. (Nasdaq: EWTX) has received authorization from the U.S. Food and Drug Administration to conduct Phase…